Home LiteratureArticle Details
PMID: 1328847 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Inhibition of voltage-gated Ca2+ channels and insulin secretion in HIT cells by the Ca2+/calmodulin-dependent protein kinase II inhibitor KN-62: comparison with antagonists of calmodulin and L-type Ca2+ channels.

Molecular pharmacology ·Vol. 42 ·No. 3 ·1992-09-00 ·Pages 489-8

Li G, Hidaka H, Wollheim CB

Abstract

To probe for the involvement of Ca2+/calmodulin-dependent protein kinase II in the regulation of insulin secretion, the effects of a specific inhibitor of this enzyme, KN-62, on secretagogue-stimulated insulin secretion, cytosolic Ca2+ concentration ([Ca2+]i) rise, membrane depolarization, and nutrient metabolism were examined in HIT-T15 cells. KN-62 dose-dependently inhibited insulin secretion induced by a nutrient mixture (10 mM glucose, 5 mM leucine, and 5 mM glutamine) alone or combined with either the Ca(2+)-mobilizing receptor agonist bombesin or the cAMP-raising agent forskolin in intact cells. KN-62 did not affect Ca(2+)- or GTP analogue-induced insulin secretion from permeabilized cells, indicating an action at a step before exocytosis. The stimulating effects of nutrients on insulin secretion, [Ca2+]i, and membrane depolarization were potentiated by bombesin. Similarly, bombesin promoted a larger depolarization and [Ca2+]i rise in the presence of nutrients. This was associated with enhanced Ca2+ mobilization and the appearance of sustained [Ca2+]i elevation. The bombesin-induced membrane depolarization, like the nutrient effect, was inhibited by diazoxide, suggesting that this is due to closure of ATP-sensitive K+ channels. Bombesin elicited Ca2+ influx by both membrane potential-sensitive and -insensitive conductance pathways. KN-62 did not affect Ca2+ mobilization and only partially reduced Ca2+ entry during the sustained [Ca2+]i rise in bombesin-stimulated cells. When added before or during the stimulation, KN-62 dose-dependently inhibited nutrient- and KCl-stimulated [Ca2+]i elevation and Mn2+ influx (reflecting Ca2+ entry). The calmodulin antagonist CGS 9343B and the L-type Ca2+ channel blocker SR-7037 mimicked the inhibitory effect of KN-62 on stimulated insulin secretion and [Ca2+]i elevation. Membrane depolarization and nutrient metabolism (reduction of a tetrazolium derivative), however, were not altered by KN-62 treatment, indicating that the early coupling events from nutrient metabolism to closure of ATP-sensitive K+ channels remain operative. These results suggest that KN-62 and the calmodulin antagonist CGS 9343B inhibit Ca2+ influx by means of direct interaction with L-type Ca2+ channels, which, in turn, causes inhibition of stimulated insulin secretion. Thus, it appears that Ca2+/calmodulin-dependent protein kinase II is not involved in the regulation of insulin secretion.

MeSH Terms
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/analogs & derivatives Animals Benzimidazoles/pharmacology Calcium/metabolism Calcium Channel Blockers/pharmacology Calcium Channels/drug effects,physiology Calcium-Calmodulin-Dependent Protein Kinases Calmodulin/antagonists & inhibitors Cell Membrane Permeability/drug effects Colforsin/pharmacology Cricetinae Diphosphonates/pharmacology Drug Synergism Insulin/metabolism Insulin Secretion Insulinoma Ion Channel Gating/drug effects,physiology Isoquinolines/pharmacology Manganese/metabolism Membrane Potentials/drug effects Mitochondria/drug effects,enzymology Piperazines/pharmacology Protein Kinase Inhibitors Stimulation, Chemical Tumor Cells, Cultured
Chemicals
Benzimidazoles Calcium Channel Blockers Calcium Channels Calmodulin Diphosphonates Insulin Isoquinolines Piperazines Protein Kinase Inhibitors belfosdil CGS 9343B Colforsin Manganese KN 62 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine Calcium-Calmodulin-Dependent Protein Kinases Calcium
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Li G
Département de Médecine, Centre Médical Universitaire, Geneva, Switzerland.
Hidaka H
Wollheim C B
Article Info
Journal
Molecular pharmacology
Abbr.
Mol Pharmacol
ISSN
0026-895X
Published
1992-09-00
Pages
489-8
Language
English
Region
United States
NLM ID
0035623
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]